Literature DB >> 31559063

The use of magnetic resonance imaging in differential diagnosis of allergic fungal sinusitis and eosinophilic mucin rhinosinusitis.

Yifan Meng1, Luo Zhang1,2,3, Yingshi Piao4, Hongfei Lou1, Kuiji Wang1, Chengshuo Wang1.   

Abstract

BACKGROUND: Allergic fungal sinusitis (AFS) and eosinophilic mucin rhinosinusitis (EMRS) represent pathophysiological variants of sinusitis and have similar clinical features. However, to date, few studies have described the differential diagnosis of AFS and EMRS in detail. We therefore investigated the use of magnetic resonance imaging (MRI) in the differential diagnosis of AFS and EMRS.
METHODS: Ninety-three patients (aged 13-75 years) with sinusitis and AFS or EMRS established according to pathological, clinical, or laboratory examinations were enrolled. Each patient was evaluated for demographic and clinical characteristics, fungal-specific immunoglobulin E, peripheral blood eosinophils, histopathology of the sinuses, as well as signal attenuation within the opacified sinuses on computed tomography and MRI scans.
RESULTS: Thirty patients presented with AFS and 63 with EMRS. The histopathological characteristics of the secretion and mucosa in the affected sinuses, but not the absolute counts or percentage of blood eosinophils, differed between the 2 groups. The presence of asthma was significantly higher in the EMRS group, whereas allergy to fungi and T2-weighted MRI signal attenuation were significantly increased in the AFS group.
CONCLUSIONS: MRI features are key to the differential diagnosis of AFS and EMRS.

Entities:  

Keywords:  Allergic fungal sinusitis (AFS); eosinophilic mucin rhinosinusitis (EMRS); magnetic resonance imaging (MRI); receiver operating characteristic (ROC) curve

Year:  2019        PMID: 31559063      PMCID: PMC6753439          DOI: 10.21037/jtd.2019.07.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  28 in total

1.  Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity.

Authors:  B J Ferguson
Journal:  Laryngoscope       Date:  2000-05       Impact factor: 3.325

Review 2.  A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis.

Authors:  Joachim E Fischer; Lucas M Bachmann; Roman Jaeschke
Journal:  Intensive Care Med       Date:  2003-05-07       Impact factor: 17.440

3.  'Eosinophilic fungal rhinosinusitis': a common disorder in Europe?

Authors:  Hannes Braun; Walter Buzina; Kurt Freudenschuss; Alfred Beham; Heinz Stammberger
Journal:  Laryngoscope       Date:  2003-02       Impact factor: 3.325

4.  The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications.

Authors:  Ramzi T Younis; Vinod K Anand; Beverly Davidson
Journal:  Laryngoscope       Date:  2002-02       Impact factor: 3.325

Review 5.  Allergic fungal rhinosinusitis: current theories and management strategies.

Authors:  B F Marple
Journal:  Laryngoscope       Date:  2001-06       Impact factor: 3.325

6.  Eosinophilic mucus chronic rhinosinusitis: clinical subgroups or a homogeneous pathogenic entity?

Authors:  Harshita Pant; Frank E Kette; William B Smith; Peter J Macardle; Peter J Wormald
Journal:  Laryngoscope       Date:  2006-07       Impact factor: 3.325

7.  Clinical presentation of allergic fungal sinusitis in children.

Authors:  John E McClay; Brad Marple; Lav Kapadia; Michael J Biavati; Brian Nussenbaum; Mark Newcomer; Scott Manning; Tim Booth; Nathan Schwade
Journal:  Laryngoscope       Date:  2002-03       Impact factor: 3.325

Review 8.  Allergic fungal sinusitis: pathogenesis and management strategies.

Authors:  Mark S Schubert
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Categorization of eosinophilic chronic rhinosinusitis.

Authors:  Berrylin J Ferguson
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-06       Impact factor: 2.064

10.  Allergic fungal sinusitis: radiological and microbiological features of 59 cases.

Authors:  Surayie H Al-Dousary
Journal:  Ann Saudi Med       Date:  2008 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.